PANoptosis in microbial infection
•Cells exposed to TLR ligands and cytokines during infection activate PANoptosis.•RIPK1-dependent PANoptosome is formed when cell survival signaling is inhibited.•Influenza A virus Z-RNAs bind and activate ZBP1, promoting PANoptosome formation. The immune system has evolved multiple mechanisms to re...
Saved in:
Published in | Current opinion in microbiology Vol. 59; pp. 42 - 49 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.02.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 1369-5274 1879-0364 1879-0364 |
DOI | 10.1016/j.mib.2020.07.012 |
Cover
Summary: | •Cells exposed to TLR ligands and cytokines during infection activate PANoptosis.•RIPK1-dependent PANoptosome is formed when cell survival signaling is inhibited.•Influenza A virus Z-RNAs bind and activate ZBP1, promoting PANoptosome formation.
The immune system has evolved multiple mechanisms to restrict microbial infections and regulate inflammatory responses. Without appropriate regulation, infection-induced inflammatory pathology can be deadly. The innate immune system recognizes the microbial molecules conserved in many pathogens and engages a rapid response by producing inflammatory mediators and activating programmed cell death pathways, including pyroptosis, apoptosis, and necroptosis. Activation of pattern recognition receptors, in combination with inflammatory cytokine-induced signaling through death domain-containing receptors, initiates a highly interconnected cell death process called PANoptosis (pyroptosis, apoptosis, necroptosis). Broadly speaking, PANoptosis is critical for restricting a wide range of pathogens (including bacteria, viruses, fungi, and parasites), which we describe in this review. We propose that re-examining the role of cell death and inflammatory cytokines through the lens of PANoptosis will advance our understanding of host–pathogen evolution and may reveal new treatment strategies for controlling a wide range of infectious diseases. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
ISSN: | 1369-5274 1879-0364 1879-0364 |
DOI: | 10.1016/j.mib.2020.07.012 |